The relationship between mean platelet volume, in-vitro platelet function tests and microvascular comp-lications in type II diabetes mellitus;Tip II diabetes mellitus'ta ortalama trombosit hacmi ve i̇n-vitro trombosit agregasyon testlerinin mikrovasküler komplikasyonlarla i̇lişkisi

THOD - Turk Hematoloji-Onkoloji Dergisi

Volumn 14, Issue 4, 2004, Pages 193-199

  Aydinli, Selahattin ^a   Saydam, Güray ^a   Şahin, Fahri ^a   Tüzün, Mehmet ^a   Büyükkeçeci, Filiz ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Microvascular complications; Platelet volume and aggregation; Type II diabetes mellitus

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN;

ADULT; ARTICLE; BLOOD CLOTTING PARAMETERS; CONTROLLED STUDY; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE VOLUME; VASCULAR DISEASE;

EID: 13244295518     PISSN: 13018825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Clark CM, Jr and Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 332:1210-1217, 1995.
2. Vranes D, Cooper ME and Dilley RJ. Cellular mechanisms of diabetic vascular hypertrophy. Microvasc Res 57:8-18, 1999.
3. Hsueh WA and Anderson PW. Systemic hypertension and the renin-angiotensin system in diabetic vascular complications. Am J Cardiol 72, 14H-21H, 1993.
4. Lehoux S and Tedgui A. Signal transduction of mechanical stresses in the vascular wall. Hypertension 32:338-345, 1998.
5. Knobler H, Savion N, Shenkman B, et al. Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients. Thromb Res 90:181-190, 1998.
6. Inaba T, Ishibashi S, Gotoda T, et al. Enhanced expression of platelet-derived growth factor-beta receptor by high glucose. Involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes 45:507-512, 1996.
7. Ceriello A: Coagulant activation in diabetes mellitus: the role of hiperglycaemia and therpeutic prospects. Diabetelogia 36:1119-25, 1993.
8. Keskin A, Sermez Y, Özgen G, Büyükkeçeci F, Yilmaz C: Fibrinolytic activity in type 2 diabetes mellitus and effect of glycemic control on fibrinolytic parameters. Turk J Med Rers 13(2):74-77, 1995.
9. Feener EP and King GL. Vascular dysfunction in diabetes mellitus. Lancet 350 (suppl 1):19-113, 1997.
10. Hayoz D, Ziegler T, Brunner HR and Ruiz J. Diabetes mellitus and vascular lesions. Metabolism 47:16-19, 1998.
11. Bridges JM, Dalby AM, Millar JHD, et al. An effect of -glucose on platelet stickiness. Lancet 1:75-77, 1965.
12. Kwaan HC, Colwell JA, Cruz S,et al. Increased platelet aggregation in diabetes mellitus. J. Lab. Clin. Med. 80:236-246, 1972.
13. J. Watanabe, H.J. Wohltmann, R.L. Klein, J.A. Colwell and M.F. Lopes-Virella, Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients. Diabetes 37:1652-1657, 1988.
14. Van Zile J, Kilpatrick M, Laimins M, et al. Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients. Diabetes 30:575-582, 1981.
15. Rao AK, Goldberg RE, Walsh PN. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume. J Lab Clin Med Jan;103(1):82-92, 1984.
16. Mazzanti L and Mutus B. Diabetes-induced alterations in platelet metabolism. Clin. Biochem. 30:509-515, 1997.
17. Berk BC, Alexander RW, Brock TA, et al. Vasoconstriction: a new activity for platelet derived growth factor. Science 232:87-90, 1986.
18. Rosenblum WI. Platelet adhesion and aggregation without endothelial denudation or exposure of basal lamina and/or collagen. J Vasc Res 34:409-417, 1997.
19. Carter AM, Grant PJ: Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin dependent diabetes mellitus. Diabet Med 14:423-432, 1997.
20. Jilma B, Fashing P, Ruthner C, et al. Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 76:328-332, 1996.
21. Rauch U, Schwippen B, Schutheiss HP, et al. Platelet activation in diabetic microangiopathy. Platelets (9):237-40, 1998.
22. Collier A, Watson HH, Patrick AW, et al. Effect of glycemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabet Metab 15:420-425, 1989.
23. Coppola L, Verrazzo G, La Marca C, et al. Effect of insulin on blood rheology in non-diabetic subjects and in patients with type 2 diabetes mellitus. Diabet. Med. 14:959-963, 1997.
24. Mayfield RK, Halushka PV, Wohltmann HJ, et al. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes 34:1127-1133, 1985.
25. Davi G, Gresele P, Violo P, et al. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo - evidence derived from the study of peripheral arterial disease. Circulation 96:69-75, 1997.